Chengdu Olymvax Biopharmaceuticals Inc.

SHSE:688319 Voorraadrapport

Marktkapitalisatie: CN¥4.2b

Chengdu Olymvax Biopharmaceuticals Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Shaowen Fan

Algemeen directeur

CN¥713.5k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO14.8yrs
Eigendom CEO3.9%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur8.4yrs

Recente managementupdates

Recent updates

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Oct 09
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

Sep 30
We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt

What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Jun 24
What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You

Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

May 28
Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?

Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

Apr 18
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely

These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

Mar 26
These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively

CEO

Shaowen Fan (71 yo)

14.8yrs

Tenure

CN¥713,500

Compensatie

Mr. Shaowen Fan is Chairman of the Board & GM of Chengdu Olymvax Biopharmaceuticals Inc. from January 2010. Mr. Fan joined the Chengdu Olymvax Biopharmaceuticals Inc. in 2010.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Shaowen Fan
Chairman of the Board & GM14.8yrsCN¥713.50k3.86%
CN¥ 161.1m
Yunhui Yu
Director11.4yrsCN¥42.00k0.014%
CN¥ 575.9k
Pengfei Zhang
Chairman of Supervisory Board8.4yrsgeen gegevens6.38%
CN¥ 266.2m
Fan Fan
Executive Deputy GM & Vice Chairman of the Board14.8yrsCN¥633.20k7.53%
CN¥ 314.3m
Cheng Hu
Director2.5yrsCN¥42.00k1.64%
CN¥ 68.5m
Aimin Chen
Director14.8yrsCN¥602.00k0.15%
CN¥ 6.3m
Lu Lu
Employee Representative Director2.5yrsCN¥195.00k0.067%
CN¥ 2.8m
Shao Ping He
Independent Director5.6yrsCN¥83.90kgeen gegevens
Hua Yan
Supervisor2.5yrsgeen gegevens0.20%
CN¥ 8.4m

8.4yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 688319 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.4 jaar).